TGF-β1 induced transdifferentiation of rpe cells is mediated by TAK1.
TGF-β1 induced transdifferentiation of rpe cells is mediated by TAK1.
复制标题
DOI:
10.1371/journal.pone.0122229
复制
发表时间:
2015
期刊:
影响因子:
3.7
通讯作者:
Pollack A
中科院分区:
文献类型:
--
作者:
Dvashi Z;Goldberg M;Adir O;Shapira M;Pollack A
Proliferative vitreoretinopathy (PVR) is an active process that develops as a complication upon retinal detachment (RD), accompanied by formation of fibrotic tissue. The main cells involved in the development of fibrotic tissue during PVR are the retinal pigment epithelial (RPE) cells. The RPE cells undergo epithelial-mesenchymal transition (EMT) which leads to complex retinal detachment and loss of vision. Transforming growth factor-β1 (TGF-β1) is considered as the main player in the EMT of RPE cells, even though the mechanism is not fully understood. This study was performed to determine the possible involvement of transforming growth factor β activated kinase 1 (TAK1) in the EMT process of the RPE cells. ARPE-19 Cells were treated with 5Z-7 oxozeaenol (TAK1 inhibitor) or SB431542 (TGF-β1 receptor kinase inhibitor) followed by TGF-β1 stimulation. Immunofluorescence, scratch assay Real time PCR and collagen contraction assay assessed the EMT features. The phosphorylation of Smad2/3 and p38 was examined using western blots analysis. This study demonstrates that stimulation of RPE cells with TGF-β1 increases α-SMA expression, cell migration and cell contractility, all of which are EMT features. Remarkably, addition of TAK1 inhibitor abolishes all these processes. Furthermore, we show hereby that TAK1 regulates not only the activation of the non-canonical cascade of TGF-β1 (p38), but also the canonical cascade, the Smad2/3 activation. Thus, the outcome of the TGF-β response in RPE cells is TAK1 dependent. This work demonstrated TAK1, a component of the non-canonical pathway of TGF-β1, is a key player in the EMT process, thus provides deep insight into the pathogenesis of PVR. The ability to halt the process of EMT in RPE cells may reduce the severity of the fibrotic response that occurs upon PVR, leading to a better prognosis and increase the probability of success in RD treatment.
登录
查看更多内容
影响因子:
9
作者:
通讯作者:
--
影响因子:
4.8
作者:
Hanada, M;Ninomiya-Tsuji, J;Tamura, S
通讯作者:
Tamura, S
影响因子:
4.4
作者:
He, Shikun;Chen, Youxin;Hinton, David R.
通讯作者:
Hinton, David R.
DOI:
10.1152/ajprenal.00485.2006
发表时间:
2007-05-01
影响因子:
4.2
作者:
Kim, Sung Il;Kwak, Joon Hyeok;Choi, Mary E.
通讯作者:
Choi, Mary E.
DOI:
10.1152/ajprenal.00018.2011
发表时间:
2011-06-01
影响因子:
4.2
作者:
Ma, Frank Y.;Tesch, Greg H.;Nikolic-Paterson, David J.
通讯作者:
Nikolic-Paterson, David J.